Optigen processes whole-genome and exome sequencing data for clinical diagnosis and research, offering variant calling, annotation and report generation optimised for Australian rare disease networks and genomic medicine centres. The Perth biotech team maintains partnerships with Telethon Kids Institute and major pathology networks, providing turnkey workflows that reduce analysis time from weeks to hours. Their platform is accredited under NATA standards and processes over 2,000 patient genomes monthly.